Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have a higher risk of heart disease.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Analyzing bear poop helps measure their stress without harming them.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Activating Tgr5 may help treat hair loss and bone loss.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Females generally have stronger immune responses than males due to the X chromosome.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.